| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2011PLoSO...629260J |
| P356 | DOI | 10.1371/JOURNAL.PONE.0029260 |
| P932 | PMC publication ID | 3237609 |
| P698 | PubMed publication ID | 22195035 |
| P5875 | ResearchGate publication ID | 51921150 |
| P50 | author | Elisa Matas-Rico | Q58240134 |
| Kees Jalink | Q42801368 | ||
| P2093 | author name string | Wouter H Moolenaar | |
| Maikel Jongsma | |||
| Adrian Rzadkowski | |||
| P2860 | cites work | Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP | Q22008544 |
| Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay | Q24654730 | ||
| Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1 | Q28210011 | ||
| Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor | Q28216396 | ||
| Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes | Q28237640 | ||
| GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5 | Q28246106 | ||
| LPA receptors: subtypes and biological actions | Q28269613 | ||
| International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature | Q30429523 | ||
| Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells | Q30434947 | ||
| Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts | Q30436718 | ||
| Role of LPA4/p2y9/GPR23 in negative regulation of cell motility | Q30440331 | ||
| Spatial regulation of the cAMP-dependent protein kinase during chemotactic cell migration | Q30476244 | ||
| Ca2+ influx is an essential component of the positive-feedback loop that maintains leading-edge structure and activity in macrophages | Q30480286 | ||
| cAMP-dependent axon guidance is distinctly regulated by Epac and protein kinase A. | Q51920488 | ||
| Polarized expression of human P2Y receptors in epithelial cells from kidney, lung, and colon | Q80961503 | ||
| Elevation of intracellular cyclic AMP inhibits NF-kappaB-mediated thymosin beta4 expression in melanoma cells | Q84010261 | ||
| Integrin-mediated protein kinase A activation at the leading edge of migrating cells | Q30484290 | ||
| LPA5 Is Abundantly Expressed by Human Mast Cells and Important for Lysophosphatidic Acid Induced MIP-1β Release | Q33862583 | ||
| Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases | Q34148745 | ||
| A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. | Q34156405 | ||
| Signalling and crosstalk of Rho GTPases in mediating axon guidance. | Q34168199 | ||
| A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migration | Q34362408 | ||
| Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator | Q34650064 | ||
| GPR92/LPA₅ lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques | Q34682812 | ||
| Regulation of actin-based cell migration by cAMP/PKA. | Q35832749 | ||
| Calcium flickers steer cell migration. | Q36421574 | ||
| Pleckstrin homology (PH) domains and phosphoinositides | Q36711258 | ||
| cAMP signaling in leukocyte transendothelial migration | Q36755290 | ||
| Regulation and biological activities of the autotaxin-LPA axis. | Q36801833 | ||
| Two pathways for lysophosphatidic acid production | Q37214057 | ||
| The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer | Q37215096 | ||
| Protein kinase B (PKB/Akt), a key mediator of the PI3K signaling pathway | Q37762205 | ||
| Autotaxin and LPA receptor signaling in cancer | Q37946291 | ||
| cAMP inhibits cell migration by interfering with Rac-induced lamellipodium formation | Q38291177 | ||
| Identification of genes that regulate epithelial cell migration using an siRNA screening approach | Q39892281 | ||
| Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation | Q39987593 | ||
| LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells | Q40133987 | ||
| Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid | Q40289797 | ||
| Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. | Q40595347 | ||
| Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines | Q40595725 | ||
| The pleckstrin homology domains of protein kinase B and GRP1 (general receptor for phosphoinositides-1) are sensitive and selective probes for the cellular detection of phosphatidylinositol 3,4-bisphosphate and/or phosphatidylinositol 3,4,5-trisphos | Q40913468 | ||
| Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling | Q41024128 | ||
| Spatial distribution of protein kinase A activity during cell migration is mediated by A-kinase anchoring protein AKAP Lbc. | Q42446982 | ||
| The bioactive phospholipid lysophosphatidic acid is released from activated platelets. | Q42796873 | ||
| Selective cellular effects of overexpressed pleckstrin-homology domains that recognize PtdIns(3,4,5)P3 suggest their interaction with protein binding partners. | Q42809330 | ||
| Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity | Q44480790 | ||
| In vitro genetic screen identifies a cooperative role for LPA signaling and c-Myc in cell transformation. | Q46397627 | ||
| The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor | Q46974695 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e29260 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptor | |
| P478 | volume | 6 |
| Q35901295 | A New Generation of FRET Sensors for Robust Measurement of Gαi1, Gαi2 and Gαi3 Activation Kinetics in Single Cells |
| Q50204216 | Angiogenesis for tumor vascular normalization of Endostar on hepatoma 22 tumor-bearing mice is involved in the immune response |
| Q34980426 | Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis |
| Q50074055 | Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development |
| Q28307790 | Autotaxin: structure-function and signaling |
| Q89200433 | Autotaxin⁻Lysophosphatidic Acid Signaling in Alzheimer's Disease |
| Q52353297 | Cell motility in cancer invasion and metastasis: insights from simple model organisms. |
| Q38035634 | Current progress in non-Edg family LPA receptor research |
| Q38223013 | Design of anticancer lysophosphatidic acid agonists and antagonists |
| Q35533312 | Diverse roles of LPA signaling in the intestinal epithelium |
| Q38949843 | Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma |
| Q35633633 | Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma. |
| Q30843450 | Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device |
| Q88788103 | Expression of lysophosphatidic acid receptor 5 is necessary for the regulation of intestinal Na+/H+ exchanger 3 by lysophosphatidic acid in vivo |
| Q41020763 | Flat clathrin lattices are dynamic actin-controlled hubs for clathrin-mediated endocytosis and signalling of specific receptors |
| Q35181424 | Krüppel-like factor 5 incorporates into the β-catenin/TCF complex in response to LPA in colon cancer cells |
| Q33825153 | LPA receptor signaling: pharmacology, physiology, and pathophysiology |
| Q91876288 | Lysophosphatidic Acid Receptors: Biochemical and Clinical Implications in Different Diseases |
| Q36177654 | Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer Cells |
| Q50033913 | Lysophosphatidic acid regulates the motility of MCF10CA1a breast cancer cell sheets via two opposing signaling pathways |
| Q54329366 | Lysophosphatidic acid stimulates cell migration of satellite cells. A role for the sphingosine kinase/sphingosine 1-phosphate axis. |
| Q27313853 | Melanoma cells break down LPA to establish local gradients that drive chemotactic dispersal |
| Q35904954 | Modulation of Hexadecyl-LPA-Mediated Activation of Mast Cells and Microglia by a Chemical Probe for LPA5. |
| Q38660494 | Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer |
| Q50227867 | Moving in and Out: Dispersion of Cells in Self-Generated Gradients |
| Q38280527 | New insights into the autotaxin/LPA axis in cancer development and metastasis |
| Q38019744 | Pleiotropic activity of lysophosphatidic acid in bone metastasis |
| Q57067868 | Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis |
| Q38320338 | Promising pharmacological directions in the world of lysophosphatidic Acid signaling |
| Q30734428 | Rapid Remodeling of Invadosomes by Gi-coupled Receptors: DISSECTING THE ROLE OF Rho GTPases. |
| Q91654129 | Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis |
| Q33786333 | Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells |
| Q27015257 | Role of the autotaxin–lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy |
| Q51489523 | Roles of LPA receptor signaling in breast cancer |
| Q35628694 | Uncovering unique roles of LPA receptors in the tumor microenvironment |
Search more.